Raptor Metals Ltd
Raptor Metals Limited, formerly Eastern Metals Limited, is an Australia-based exploration company dedicated to advancing high-potential copper, zinc, gold, and nickel projects in premier mining jurisdictions.
The business
Raptor Metals Limited, formerly Eastern Metals Limited, is an Australia-based exploration company dedicated to advancing high-potential copper, zinc, gold, and nickel projects in premier mining jurisdictions. It is engaged in building a diversified portfolio in Canada’s Bathurst Mining Camp and Western Australia's Eastern Goldfields. Its projects include Chester, Turgeon, Arunta, and Emu Lake Project. The Chester Project consists of 70 km SW of Bathurst City, 50 km WNW of Miramichi City. It has 281 mineral claims covering 6,176 hectares. The Turgeon Project is located three km SW of Belledune City, 30 km NW of Bathurst City. It owns 31 mineral claims covering 715 hectares in two contiguous blocks. The Arunta Project is located 290 km northeast of Alice Springs, within the Northern Arunta Pegmatite Province. The Emu Lake Project is located 75 km NE of Kalgoorlie, in an under-explored greenstone belt. It owns two granted Exploration Licences and three applications covering over 74 km2.
Small Caps Research
No research on Raptor Metals Ltd yet
We cover the ASX small-cap market one company at a time. Request coverage and we’ll prioritise RAP based on demand.
Share price
Market Statistics
Valuation
Trading Activity
Performance
Latest news
ResApp Health’s takeover bid from Pfizer shaved by $53m after disappointing study results
ResApp Health’s (ASX: RAP) shares sank 30% this week after the company announced less than impressive study results on its COVID-19 cough detection app, which has resulted in $53 million being immediately erased from Pfizer’s proposed takeover bid. The Queensland-based digital health firm caught Pfizer’s attention in April, when a March pilot study of the […]
ResApp Health unveils at-home sleep apnoea screening app
Digital health company ResApp Health (ASX: RAP) has unveiled a new smartphone app that can be used in the home to assess a person’s risk of obstructive sleep apnoea. According to ResApp, the SleepCheck app uses clinically accurate algorithms to analyse the consumer’s breathing and snoring sounds during sleep. The app does not require any […]
ResApp and Coviu team up to provide remote respiratory tests through telehealth platform
Digital health company ResApp Health (ASX: RAP) has inked a binding deal to integrate its ResAppDx-EU diagnostic test into Coviu’s telehealth platform to enable clinicians to perform respiratory assessments remotely. ResAppDx-EU is a smartphone-based acute respiratory disease diagnostic test that uses machine learning algorithms to analyse a patient’s cough sounds to diagnose lower respiratory tract […]
ResApp Health locks-in Australian TGA approval for smartphone respiratory diagnostic technology in adults
ResApp Health (ASX: RAP) has finally locked-in Australian Therapeutic Goods Administration for using its smartphone-based diagnostic technology to determine respiratory disease in adults. This latest milestone follows TGA approval in October to use its respiratory diagnostic technology in paediatrics. ResApp’s smartphone application ResAppDx-EU version two can now be used to diagnose respiratory disease in both […]
Looking for charts & signals? See the tab.
Unlock the full research library - free.
Create a free account to access every broker report, CEO interview, IPO alert, and daily market wrap. No credit card. No paywall.